These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38163934)

  • 1. Novel Strategies for Preventing Dysbiosis in the Oral Cavity.
    Rebelo MB; Oliveira CS; Tavaria FK
    Front Biosci (Elite Ed); 2023 Oct; 15(4):23. PubMed ID: 38163934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral microbiota in human health and disease: A perspective.
    Santacroce L; Passarelli PC; Azzolino D; Bottalico L; Charitos IA; Cazzolla AP; Colella M; Topi S; Godoy FG; D'Addona A
    Exp Biol Med (Maywood); 2023 Aug; 248(15):1288-1301. PubMed ID: 37688509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outside the limits of bacterial viability: Postbiotics in the management of periodontitis.
    Moraes RM; Schlagenhauf U; Anbinder AL
    Biochem Pharmacol; 2022 Jul; 201():115072. PubMed ID: 35513043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation.
    Di Stefano M; Santonocito S; Polizzi A; Mauceri R; Troiano G; Lo Giudice A; Romano A; Mascitti M; Isola G
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradigm shift in the pathogenesis and treatment of oral cancer and other cancers focused on the oralome and antimicrobial-based therapeutics.
    Radaic A; Ganther S; Kamarajan P; Grandis J; Yom SS; Kapila YL
    Periodontol 2000; 2021 Oct; 87(1):76-93. PubMed ID: 34463982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive review of the application of probiotics and postbiotics in oral health.
    Homayouni Rad A; Pourjafar H; Mirzakhani E
    Front Cell Infect Microbiol; 2023; 13():1120995. PubMed ID: 36968114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial modulation of human health in the oral cavity and beyond using bacteriocin-like inhibitory substance-producing streptococcal probiotics.
    Tagg JR; Harold LK; Jain R; Hale JDF
    Front Microbiol; 2023; 14():1161155. PubMed ID: 37056747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis.
    Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL
    World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of Saliva-Derived Microcosm Biofilms To Resemble Dysbiotic Subgingival Microbiota.
    Jiang Y; Brandt BW; Buijs MJ; Cheng L; Exterkate RAM; Crielaard W; Deng DM
    Appl Environ Microbiol; 2021 Jan; 87(3):. PubMed ID: 33158898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Probiotic
    Araujo LDC; Furlaneto FAC; da Silva LAB; Kapila YL
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resilience of the Oral Microbiota in Health: Mechanisms That Prevent Dysbiosis.
    Rosier BT; Marsh PD; Mira A
    J Dent Res; 2018 Apr; 97(4):371-380. PubMed ID: 29195050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Multi-omics and Microbiome Meta-analysis Identify an Asymptomatic Gingival State That Links Gingivitis, Periodontitis, and Aging.
    Huang S; He T; Yue F; Xu X; Wang L; Zhu P; Teng F; Sun Z; Liu X; Jing G; Su X; Jin L; Liu J; Xu J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rebalancing the Caries Microbiome Dysbiosis: Targeted Treatment and Sugar Alcohols.
    Zhan L
    Adv Dent Res; 2018 Feb; 29(1):110-116. PubMed ID: 29355418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted antimicrobial therapy in the microbiome era.
    Stone VN; Xu P
    Mol Oral Microbiol; 2017 Dec; 32(6):446-454. PubMed ID: 28609586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oral microbiome in respiratory health and diseases.
    Pathak JL; Yan Y; Zhang Q; Wang L; Ge L
    Respir Med; 2021; 185():106475. PubMed ID: 34049183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental Materials for Oral Microbiota Dysbiosis: An Update.
    Zhu J; Chu W; Luo J; Yang J; He L; Li J
    Front Cell Infect Microbiol; 2022; 12():900918. PubMed ID: 35846759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic antibiotics increase microbiota pathogenicity and oral bone loss.
    Yuan X; Zhou F; Wang H; Xu X; Xu S; Zhang C; Zhang Y; Lu M; Zhang Y; Zhou M; Li H; Zhang X; Zhang T; Song J
    Int J Oral Sci; 2023 Jan; 15(1):4. PubMed ID: 36631439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postbiotics: An alternative and innovative intervention for the therapy of inflammatory bowel disease.
    Kavita ; Om H; Chand U; Kushawaha PK
    Microbiol Res; 2024 Feb; 279():127550. PubMed ID: 38016379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the Bacterial Biosynthetic Gene Clusters of the Oral Microbiome Illuminates the Unexplored Social Language of Bacteria during Health and Disease.
    Aleti G; Baker JL; Tang X; Alvarez R; Dinis M; Tran NC; Melnik AV; Zhong C; Ernst M; Dorrestein PC; Edlund A
    mBio; 2019 Apr; 10(2):. PubMed ID: 30992349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies.
    Duan H; Yu L; Tian F; Zhai Q; Fan L; Chen W
    Crit Rev Food Sci Nutr; 2022; 62(6):1427-1452. PubMed ID: 33198506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.